GlassScriptPhysician profile
Timothy J Eldridge
NPI 1679548572
$5,651.20
in general payments reported to CMS, 2019-2025
12 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,089 · 2020: $58.60 · 2021: $2,403 · 2023: $718 · 2024: $138 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722 · Travel and Lodging: $362 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.81 |
| Travel and Lodging | $362.25 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,594.63 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $2,377.37 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $181.13 | 2024-2025 | Signia, Situate |
| Pacira Pharmaceuticals Incorporated | $135.82 | 2019-2025 | Exparel |
| Endologix LLC | $86.75 | 2019 | |
| Allergan, INC. | $73.17 | 2019-2021 | |
| Covidien LP | $72.83 | 2019 | |
| Davol INC. | $45.20 | 2021-2023 | Phasix Mesh |
| Stryker Corporation | $28.82 | 2025 | 1788 |
| Abbvie INC. | $26.09 | 2023 | |
| Boston Scientific Corporation | $17.74 | 2025 | Spyglass Discover |
| Biomerieux INC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Eldridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.